Ophthalmology Doctors in Utah Medicare Details, Address, Contact
207 Ophthalmology doctors found. Showing 201 - 207
 Dr. Ron Kenneth Lord, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 585 E Riverside Drive, Suite 201, St. George, UT 84790 Phone: 435-216-7032 Fax: 866-836-9639 |
Michael Todd Griffeth, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2376 N 400 E Ste 101, Tooele, UT 84074 Phone: 435-843-8333 Fax: 435-843-8334 |
Dr. Gilbert C Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3895 W 7800 S, Suite 202, West Jordan, UT 84088 Phone: 801-948-4442 |
Dr. Douglas Stewart Mehr, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3855 W 7800 S Ste 100, West Jordan, UT 84088 Phone: 801-260-0034 Fax: 801-260-0035 |
Christopher Jordon Gee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3855 W 7800 S Ste 100, West Jordan, UT 84088 Phone: 801-260-0034 Fax: 801-260-0035 |
Dr. Andrew Davis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3855 W 7800 S Ste 100, West Jordan, UT 84088 Phone: 801-260-0034 Fax: 801-260-0035 |
Dr. Robert E Smith, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2965 W 3500 S, West Valley City, UT 84119 Phone: 801-965-3600 |
News Archive
Adrenocorticotropic hormone may help treat people with multiple sclerosis
A new study suggests that treatment with adrenocorticotropic hormone (ACTH) may be helpful for people whose multiple sclerosis (MS) is not well-controlled through their regular treatment. The study was released today and will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
HGS and GSK announce results from phase III clinical trials of BENLYSTA
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Pivotal Therapeutics reports loss of $811,164 for third quarter 2012
Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on cardiovascular disease and overall health today announced its financial results and operational highlights for the quarter ended September 30, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.
Doctor offers tips for parents on how to speak with children about disasters
David Schonfeld, MD, Director, Division of Developmental and Behavioral Pediatrics at Cincinnati Children's Hospital Medical Center and Director, National Center for School Crisis and Bereavement, gives parents the following tips on how to speak with their children after disasters have occurred.
› Verified 5 days ago
Draper (3)
Holladay (4)
Layton (8)
Logan (6)
Murray (6)
Ogden (19)
Provo (21)
Salt Lake City (92)
Sandy (4)
St George (11)
West Jordan (4)
All Cities in UT